Document Detail


The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses.
MedLine Citation:
PMID:  17982331     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The levonorgestrel containing intrauterine system is an effective and safe form of long-term yet reversible birth control. Intrauterine contraception use in the United States fell dramatically after early studies reported an association between intrauterine contraception use and later tubal infertility. Subsequent evaluation suggests that these early studies were biased. Users often experience menstrual disturbances. Informing patients of these common side effects is important to improve compliance. In addition to its contraceptive effect, the levonorgestrel intrauterine system offers potential therapeutic benefits in other clinical contexts, including menorrhagia, symptomatic fibroids, endometriosis, and endometrial suppression.
Authors:
Camaryn Chrisman; Pricilla Ribeiro; Vanessa K Dalton
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical obstetrics and gynecology     Volume:  50     ISSN:  1532-5520     ISO Abbreviation:  Clin Obstet Gynecol     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-11-05     Completed Date:  2008-02-08     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0070014     Medline TA:  Clin Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  886-97     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cost-Benefit Analysis
Endometriosis / drug therapy
Female
Female Urogenital Diseases / epidemiology,  etiology
Humans
Infertility, Female / epidemiology,  etiology
Intrauterine Devices, Medicated / adverse effects*,  standards*,  utilization
Leiomyoma / drug therapy
Menorrhagia / drug therapy
Risk Assessment
Risk Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Contraceptive vaginal ring.
Next Document:  Injectable contraception.